The FDA granted approval to Inmazep, a mixture of three monoclonal antibodies, making it the first FDA-approved treatment for Ebola virus. Regeneron Pharmaceuticals (NSDQ:REGN) received the approval, having recently been in the news for providing its investigational COVID-19 therapeutic to President Donald Trump. Get the full story at our sister site, Drug Discovery & Development.
Organizers of a "stop Ebola" hackathon planned for next week at Mass. General Hospital say the Ebola scare at MGH highlights the need for more advances to combat the outbreak.
Elizabeth Bailey, director of the Consortium of Affordable Medical Technologies, told MassDevice.com that the group was "absolutely commited" to holding the hackathon next week.